ALBANY, New York, February 11, 2013 /PRNewswire/ -- NewMarket ResearchReport Added inMarketResearchReports.BizReports DatabaseCellular Therapy and Cord Blood 2013 Market Report This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein; we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space. To Browse Full TOC, Tables & Figures visit:http://www.marketresearchreports.biz/analysis-details/cellular-therapy-and-cord-blood We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated. Related Reports Circulating Tumor Cells MarketPersonalized Medicine MarketMicroRNA MarketUmbilical Cord Blood Banking MarketSingle Cell Omics Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. Our coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood. Furthermore, given our global footprint, we've been able to compare the EU and US markets side-by-side in this analysis.